-
IR-820 (New Indocyanine Green): Precision in In Vivo Tumor I
2026-08-04
Explore how IR-820 (New Indocyanine Green) is redefining near-infrared fluorescence imaging for tumor and vascular research. This article delivers advanced protocol insights, molecular rationale, and a comparative lens on assay optimization not found in existing resources.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-08-03
Recent work demonstrates that naturally occurring angiotensin peptides, including short C- and N-terminal fragments, significantly enhance the binding of SARS-CoV-2 spike protein to the AXL receptor. These findings offer mechanistic insight into the interplay between the renin-angiotensin system and viral infection, highlighting potential research avenues for both cardiovascular and infectious disease studies.
-
HA-mRNA Vaccine Protects Dairy Cows Against H5N1 Challenge
2026-08-03
This study demonstrates that a hemagglutinin-based mRNA–lipid nanoparticle vaccine confers robust and lasting protection against H5N1 influenza virus in lactating dairy cows. The findings highlight the vaccine’s safety, immunogenicity, and potential for managing zoonotic threats in agricultural settings.
-
VER 155008: HSP 70 Inhibitor Workflows in Cancer Research
2026-08-02
VER 155008, a potent adenosine-derived HSP 70 inhibitor, empowers precise dissection of heat shock protein signaling in cancer and viral entry models. This guide delivers advanced experimental workflows, troubleshooting strategies, and protocol enhancements that maximize the translational impact of VER 155008 for apoptosis and cancer cell proliferation assays.
-
Cholecystokinin Octapeptide Ammonium: Mechanisms and Researc
2026-08-01
Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is a sulfated peptide that modulates opioid analgesia, anxiety, apoptosis, and immune responses via CCK1R/CCK2R. It acts through defined G protein–coupled receptor pathways and is essential for studies of neurobehavior and cardiovascular signaling. APExBIO provides a validated CCK-8 ammonium product (SKU C8717) that is widely used in bench research.
-
PA-824: Mechanistic Insights and Strategic Advances in Tuber
2026-07-31
Explore the scientific foundation of PA-824, a potent bicyclic nitroimidazole derivative, and discover how its unique dual-action mechanism advances tuberculosis research. This article offers a fresh, in-depth analysis of PA-824's mechanistic role and strategic assay design, setting it apart from existing literature.
-
ACSL4 Drives Endometrial Decidualization via Fatty Acid β-Ox
2026-07-31
This study establishes long-chain acyl-CoA synthetase-4 (ACSL4) as a crucial regulator of endometrial decidualization, acting through fatty acid β-oxidation rather than lipid droplet accumulation. The findings clarify a key metabolic mechanism underlying embryo implantation, with implications for reproductive medicine and cAMP pathway research.
-
Trelagliptin Succinate Promotes Osteoblast Differentiation v
2026-07-30
This study reveals that Trelagliptin succinate, a DPP-4 inhibitor commonly used in type 2 diabetes research, significantly enhances osteoblastic differentiation and mineralization in vitro by upregulating RUNX2 through the AMPK pathway. These findings point to new potential for Trelagliptin in osteoporosis research, bridging metabolic and bone biology fields.
-
Olsalazine Sodium: Applied Workflows in Cancer and Vector Re
2026-07-30
Olsalazine Sodium, a potent mesalamine dimer, advances both inflammation and cancer studies with its unique LTB4 chemotaxis inhibition and proven tumor suppression. Recent cross-domain findings in mosquito xenobiotic transport highlight new functional workflows, enabling researchers to bridge molecular biology with translational applications.
-
NBC19 and the NLRP3 Inflammasome: Precision Tools for Studyi
2026-07-29
Discover how NBC19, a potent NLRP3 inflammasome inhibitor, advances inflammation research and tumor microenvironment studies. This article uniquely bridges cutting-edge macrophage biology with optimized assay protocols for translational research.
-
Tin Mesoporphyrin IX (chloride): Defining HO Assay Precision
2026-07-29
Explore how Tin Mesoporphyrin IX (chloride) enables ultra-sensitive, reproducible heme oxygenase activity assays and unlocks new insights in metabolic disease research. This article delivers a unique, evidence-based perspective linking mechanistic depth with practical protocol optimization.
-
Phosphatase Inhibitor Cocktail 1: Precision Tools for Phosph
2026-07-28
Discover how Phosphatase Inhibitor Cocktail 1 (100X in DMSO) advances protein phosphorylation preservation for phosphoproteomic analysis. Explore unique mechanistic insights, protocol strategies, and the latest translational evidence.
-
In Vitro Drug Response Assessment in Cancer: Advances and To
2026-07-28
Schwartz's dissertation proposes a refined framework for in vitro evaluation of anti-cancer drug responses, distinguishing between growth inhibition and cell death metrics. This work highlights the necessity for precise measurement techniques and has implications for improving experimental reproducibility in preclinical cancer studies.
-
Nelfinavir Mesylate: Applied HIV-1 Protease Inhibitor Workfl
2026-07-27
Nelfinavir Mesylate stands out as a potent, orally bioavailable HIV-1 protease inhibitor with dual research utility in viral replication suppression and ferroptosis pathway modulation. This article delivers actionable protocols, advanced troubleshooting, and evidence-based insights for maximizing data quality in HIV and cell death pathway research.
-
Dissecting Metabolite Regulation of TET2 via Biochemical and
2026-07-27
Zhang et al. introduce a detailed protocol integrating biochemical assays with STD NMR spectroscopy to experimentally validate the binding and regulatory effects of metabolites on human TET2 dioxygenase. This workflow enables precise identification of TET2 activators and inhibitors, strengthening the mechanistic link between metabolism and epigenetic regulation.
449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page